Fitness Trends Global Deep Brain Stimulation Devices Market

Global Deep Brain Stimulation Devices Market, By
Application, and By Geography - Trends, Outlook, and
Forecast from 2016-2024
Deep brain stimulation (DBS) device, often described as brain pacemaker, aids in alleviating
symptoms of Parkinson’s disease (PD). The device is implanted at one of the three FDA
approved brain sites to block the electrical signals from these sites to the brain. The three FDA
approved targeted brain sites are ventrointermedialis (VIM) nucleus of the thalamus, subthalamic
nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is performed on patient’s
suffering from Parkinson’s disease for at least four years, and are on medications albeit with
motor complications. Though there are other surgical options such as thalamotomy and
pallidotomy, deep brain stimulation is the most preferred option, as it does not involve tissue
destruction and is a reversible surgical treatment.
For In depth Information Get Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/84
The global deep brain stimulation devices market was valued at US$ 664.4 million in 2015 and
is expected to expand at a CAGR of 8.2% during the forecast period (2016 – 2024).
Market Dynamics
Aging increases the risk of Alzheimer’s disease, Parkinson’s disease and dementia. Thus,
growing geriatric population is a major factor driving demand for deep brain stimulation
devices. Though drug therapies are available for treating these diseases, surgical procedures are
recommended in later stages of the condition. Furthermore, deep brain stimulation devices
reduce the side effects and improves patient condition by reducing incidence of tremors.
Patients are inclined towards adoption of minimally invasive procedures, as these require low
healing time and leave behind minimal scars. Surgeons too prefer such procedures as it
significantly reduces risk element from accidental damage to surrounding tissue. This is another
factor fueling demand for deep brain stimulation devices globally. However, as these devices
need to be implanted in the brain, it is extremely challenging and in turn reduces acceptance of
DBS devices among patients.